Raptor Pharm (RPTP) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts RPTP Hot Sheet
Join SI Premium – FREE
Raptor Pharm (NASDAQ: RPTP) reported Q4 EPS of ($0.37), $0.10 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.
For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
- Veralto agrees to acquire Cleanwater1 for $465 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
